Effect of medical treatments in disseminated peritoneal leiomyomatosis: a case report.
Anne-Sophie NavarroMartina Aida AngelesClaire IllacBérénice BouletGwenael FerronAlejandra MartinezPublished in: Journal of surgical case reports (2022)
Disseminated peritoneal leiomyomatosis (DPL) is a rare gynecologic disease involving multifocal proliferation of myomas. The pathogenesis remains unclear. Although there is no standard treatment, medical therapies have attempted to suppress estrogen levels by using gonadotrophin-releasing hormone agonist and aromatase inhibitor (AI) therapy with differing degrees of success. Surgery is also an option in symptomatic patients, and in the event of partial or no response to medical treatments. We report a case of DPL in a young woman with a previous history of myomectomy. She was treated sequentially with ulipristal acetate and AI.
Keyphrases
- healthcare
- end stage renal disease
- newly diagnosed
- artificial intelligence
- ejection fraction
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- signaling pathway
- coronary artery bypass
- stem cells
- coronary artery disease
- case report
- patient reported outcomes
- estrogen receptor
- machine learning
- replacement therapy
- deep learning
- percutaneous coronary intervention
- combination therapy
- smoking cessation